相关实验视频
Updated: Jan 31, 2026
36:30
Small Bowel Transplantation In Mice
Published on: August 20, 2007
15.1K
一个不常见的肠道血管瘤病例由于利西诺普利尔
Cristina Vidal Carrion1, Hannah Warshaw1, Sree Uppalapati1
1Internal Medicine, Northeast Georgia Medical Center Gainesville, Gainesville, USA.
Cureus
|January 30, 2026
概括
ангиотензин转化酶抑制剂 (ACEi) 可能导致罕见的肠道血管,呈急性腹痛. 及时诊断和使用类固醇治疗可以有效地管理这种情况.
科学领域:
- 胃肠病学 胃肠病学
- 药理学 药理学是指药理学的学科.
- 内部医学 内部医学
背景情况:
- 血管腺是一种可能是遗传性或过敏相关的胀,涉及组胺或布拉迪基宁通路.
- 来自ACE抑制剂 (ACEi) 的血管通常会影响上呼吸道,但很少会在腹内表现出来.
- 由ACEi诱导的血管是急性腹痛的关键差异诊断,特别是在高血压患者中.
研究的目的:
- 报告使用ACE抑制剂的次要肠道血管的病例.
- 要强调考虑在患有急性腹痛的患者中考虑ACEi诱导的血管的重要性.
- 讨论这种罕见疾病的诊断和管理策略.
主要方法:
- 一个病例报告,一名54岁的男性患有高血压,在开始服用利西诺普里尔-甲酸后出现急性腹痛.
- 诊断工作包括腹部的计算机断层扫描 (CT).
- 治疗包括德克萨米他,迪芬胺, famotidine,以及停止使用 ACE 抑制剂.
主要成果:
- 脑电图扫描揭示了结肠和西格结肠的加厚,带有粘膜水和炎症变化,与肠道血管相一致.
- 患者的症状随着开始治疗而消失.
- 停止使用ACE抑制剂对于恢复至关重要.
结论:
- 肠道动脉瘤是一种罕见但严重的ACE抑制剂不良反应,必须在急性腹部的差异诊断中考虑.
- 使用类固醇,抗胰岛素和H2阻断剂的实证治疗以及停止使用ACE抑制剂是有效的.
- 需要进一步的研究,以充分阐明ACEi诱导的肠道血管的机制和最佳管理.
相关概念视频
01:17Chronic Bowel Disorders: Introduction
801
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
801
01:17Irritable Bowel Syndrome I: Introduction
1.0K
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
1.0K
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
980
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
980
01:21Inflammatory Bowel Disease V: Surgical Management
516
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
516
01:30Inflammatory Bowel Disease II: Crohn's Disease
1.1K
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
1.1K
01:29Inflammatory Bowel Disease IV: Pharmacological Management
604
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
604